Skip to content
★ Sign in to follow
Total declarations
53
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (33 ops.)
€5.0M

Latest filing published 29 Apr 2021 for Abbott Laboratories, €952k.

Filing timeline

BuySale
Roger Bird

Insider track record

Disclosed buys
0
Disclosed sells
33
Signal history

Roger Bird: trading record in brief

Roger Bird is a declared insider of Abbott Laboratories, with filings sourced from SEC (Form 4). We count 53 filings; the first trade dates from 27 April 2015 and the latest from 27 April 2021.

No open-market purchase appears, only 33 sales worth €5.0M. Outside the open market, there are 15 share grants and 4 option exercises. Since January 2021: no purchases and 2 sales on the market.

Most recently, on 29 April 2021, the filings show an open-market sale worth €952k in Abbott Laboratories. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Roger Bird

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations53 total
  • ▼
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    1M USD24SEC
    9,439 shares@ US$122.0014.5% of flowCommon shares without par valueSEC:0001415889-21-002194:0
  • ◆
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    972,518 USD12SEC
    7,999 shares@ US$121.5812.2% of flowCommon shares without par valueSEC:0001415889-21-001196:0
  • ▼
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    134,239 USD29SEC
    1,113 shares@ US$120.611.7% of flowCommon shares without par valueSEC:0001415889-21-001196:1
  • ◆
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    13,004 shares0Common shares without par valueSEC:0001415889-21-000884:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    683,912 USD31SEC
    6,290 shares@ US$108.7348.7% of flowCommon shares without par valueSEC:0001179110-20-009564:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    612,614 USD16SEC
    7,736 shares@ US$79.1947.3% of flowCommon shares without par valueSEC:0001179110-20-002908:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    51,875 USD29SEC
    666 shares@ US$77.894.0% of flowCommon shares without par valueSEC:0001179110-20-002908:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    14,375 shares0Common shares without par valueSEC:0001179110-20-002263:0
  • ●
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    2,860 shares0Common shares without par valueSEC:0001104659-19-043011:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    695,728 USD32SEC
    8,800 shares@ US$79.0625.9% of flowCommon shares without par valueSEC:0001179110-19-003862:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    7,907 USD29SEC
    100 shares@ US$79.070.3% of flowCommon shares without par valueSEC:0001179110-19-003862:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    22,772 USD29SEC
    288 shares@ US$79.070.8% of flowCommon shares without par valueSEC:0001179110-19-003862:2
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    547,329 USD13SEC
    7,087 shares@ US$77.2320.2% of flowCommon shares without par valueSEC:0001179110-19-003107:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    86,814 USD29SEC
    1,113 shares@ US$78.003.2% of flowCommon shares without par valueSEC:0001179110-19-003107:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    19,021 shares0Common shares without par valueSEC:0001179110-19-002631:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    493,341 USD30SEC
    7,862 shares@ US$62.758.6% of flowCommon shares without par valueSEC:0001179110-18-004164:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    12,550 USD29SEC
    200 shares@ US$62.750.2% of flowCommon shares without par valueSEC:0001179110-18-004164:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    12,552 USD29SEC
    200 shares@ US$62.760.2% of flowCommon shares without par valueSEC:0001179110-18-004164:2
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    332,238 USD12SEC
    5,487 shares@ US$60.555.8% of flowCommon shares without par valueSEC:0001179110-18-003306:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    5,881 USD29SEC
    100 shares@ US$58.810.1% of flowCommon shares without par valueSEC:0001179110-18-003306:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    90,846 USD29SEC
    1,545 shares@ US$58.801.6% of flowCommon shares without par valueSEC:0001179110-18-003306:2
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    22,255 shares0Common shares without par valueSEC:0001179110-18-002527:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    245,392 USD26SEC
    5,600 shares@ US$43.824.8% of flowCommon shares without par valueSEC:0001179110-17-006291:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    197,751 USD11SEC
    4,350 shares@ US$45.464.0% of flowCommon shares without par valueSEC:0001179110-17-003675:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    72,077 USD29SEC
    1,601 shares@ US$45.021.5% of flowCommon shares without par valueSEC:0001179110-17-003675:1

25 of 53 declarations